<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T14:47:48Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8990939" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8990939</identifier>
        <datestamp>2022-04-22</datestamp>
        <setSpec>springeropen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Cell Mol Life Sci</journal-id>
              <journal-id journal-id-type="iso-abbrev">Cell Mol Life Sci</journal-id>
              <journal-title-group>
                <journal-title>Cellular and Molecular Life Sciences</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1420-682X</issn>
              <issn pub-type="epub">1420-9071</issn>
              <publisher>
                <publisher-name>Springer International Publishing</publisher-name>
                <publisher-loc>Cham</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8990939</article-id>
              <article-id pub-id-type="pmcid">PMC8990939</article-id>
              <article-id pub-id-type="pmc-uid">8990939</article-id>
              <article-id pub-id-type="pmid">35391557</article-id>
              <article-id pub-id-type="pmid">35391557</article-id>
              <article-id pub-id-type="publisher-id">4243</article-id>
              <article-id pub-id-type="doi">10.1007/s00018-022-04243-z</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Masini</surname>
                    <given-names>Maria Angela</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Bonetto</surname>
                    <given-names>Valentina</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Manfredi</surname>
                    <given-names>Marcello</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5783-0668</contrib-id>
                  <name>
                    <surname>Pastò</surname>
                    <given-names>Anna</given-names>
                  </name>
                  <address>
                    <email>annapasto.phd@gmail.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff10">10</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Barberis</surname>
                    <given-names>Elettra</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Timo</surname>
                    <given-names>Sara</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vanella</surname>
                    <given-names>Virginia Vita</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Robotti</surname>
                    <given-names>Elisa</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Masetto</surname>
                    <given-names>Francesca</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Andreoli</surname>
                    <given-names>Francesca</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fiore</surname>
                    <given-names>Alessandra</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tavella</surname>
                    <given-names>Sara</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sica</surname>
                    <given-names>Antonio</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Donadelli</surname>
                    <given-names>Massimo</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Marengo</surname>
                    <given-names>Emilio</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.16563.37</institution-id><institution-id institution-id-type="ISNI">0000000121663741</institution-id><institution>Department of Sciences and Innovation Technologies (DISIT), </institution><institution>University of Eastern Piedmont, </institution></institution-wrap>Alessandria, Italy </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.16563.37</institution-id><institution-id institution-id-type="ISNI">0000000121663741</institution-id><institution>Department of Translational Medicine (DIMET), </institution><institution>University of Eastern Piedmont, </institution></institution-wrap>Novara, Italy </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.417728.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1756 8807</institution-id><institution>Humanitas Clinical and Research Center, IRCCS, </institution></institution-wrap>Rozzano, Milan Italy </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.5611.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1763 1124</institution-id><institution>Department of Neurosciences, Biomedicine and Movement Sciences (DNBM), </institution><institution>University of Verona, </institution></institution-wrap>Verona, Italy </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.5606.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2151 3065</institution-id><institution>Department of Experimental Medicine (DIMES), </institution><institution>University of Genova, </institution></institution-wrap>Genova, Italy </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.16563.37</institution-id><institution-id institution-id-type="ISNI">0000000121663741</institution-id><institution>Department of Pharmaceutical Sciences (DSF), </institution><institution>University of Eastern Piedmont ‘A. Avogadro’, </institution></institution-wrap>Novara, Italy </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.410345.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1756 7871</institution-id><institution>IRCCS Ospedale Policlinico San Martino, </institution></institution-wrap>Genova, Italy </aff>
                <aff id="Aff8"><label>8</label>ISALIT, Novara, Italy </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.16563.37</institution-id><institution-id institution-id-type="ISNI">0000000121663741</institution-id><institution>CAAD, Center for Autoimmune and Allergic Disease, </institution><institution>University of Eastern Piedmont, </institution></institution-wrap>Novara, Italy </aff>
                <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>School of Cancer &amp; Pharmaceutical Sciences New Hunt’s House, </institution><institution>Guy’s Campus, King’s College London, </institution></institution-wrap>SE1 UL London, United Kingdom </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>7</day>
                <month>4</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>7</day>
                <month>4</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <year>2022</year>
              </pub-date>
              <volume>79</volume>
              <issue>5</issue>
              <elocation-id>226</elocation-id>
              <history>
                <date date-type="received">
                  <day>28</day>
                  <month>10</month>
                  <year>2021</year>
                </date>
                <date date-type="rev-recd">
                  <day>21</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>10</day>
                  <month>3</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">The impact of the absence of gravity on cancer cells is of great interest, especially today that space is more accessible than ever. Despite advances, few and contradictory data are available mainly due to different setup, experimental design and time point analyzed.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">Exploiting a Random Positioning Machine, we dissected the effects of long-term exposure to simulated microgravity (SMG) on pancreatic cancer cells performing proteomic, lipidomic and transcriptomic analysis at 1, 7 and 9 days.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Our results indicated that SMG affects cellular morphology through a time-dependent activation of Actin-based motility via Rho and Cdc42 pathways leading to actin rearrangement, formation of 3D spheroids and enhancement of epithelial-to-mesenchymal transition. Bioinformatic analysis reveals that SMG may activates ERK5/NF-κB/IL-8 axis that triggers the expansion of cancer stem cells with an increased migratory capability. These cells, to remediate energy stress and apoptosis activation, undergo a metabolic reprogramming orchestrated by HIF-1α and PI3K/Akt pathways that upregulate glycolysis and impair β-oxidation, suggesting a de novo synthesis of triglycerides for the membrane lipid bilayer formation.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">SMG revolutionizes tumor cell behavior and metabolism leading to the acquisition of an aggressive and metastatic stem cell-like phenotype. These results dissect the time-dependent cellular alterations induced by SMG and pave the base for altered gravity conditions as new anti-cancer technology.</p>
                </sec>
                <sec>
                  <title>Supplementary Information</title>
                  <p>The online version contains supplementary material available at 10.1007/s00018-022-04243-z.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Microgravity</kwd>
                <kwd>Cancer stem cells</kwd>
                <kwd>Metabolism</kwd>
                <kwd>Proteomic</kwd>
                <kwd>Lipidomic</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© Springer Nature Switzerland AG 2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Introduction</title>
              <p id="Par19">The force of gravity affects all living beings on Earth. From 1969, when men stepped on the moon, the importance of gravity was clear. During their stay in space, astronauts showed many physiological changes mainly impairing the musculoskeletal and cardiovascular system [<xref ref-type="bibr" rid="CR1">1</xref>], due to the impact of reduced gravity on cellular properties including morphology, metabolism, and proliferation. In the last years, it has grown a huge interest in the effects of the absence of gravity on tumor cells in order to exploit microgravity for the development of novel anti-cancer therapies. In gravity-altered conditions, cancer cells behave differently from healthy ones: some processes, including apoptosis, adhesion, proliferation, and migration, are differently activated in cancer cells [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Indeed, it was demonstrated that microgravity induces apoptosis [<xref ref-type="bibr" rid="CR3">3</xref>] through the up-regulation of the pro-apoptotic factors Bax, PARP and p53, and inhibition of proliferation of cancer cells, but not of healthy cells. In addition, tumor cells are subjected to profound morphological rearrangement, linked to F-actin accumulation [<xref ref-type="bibr" rid="CR4">4</xref>]. We and others [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>] proved that cytoskeleton, in particular the microfilamentous and microtubular components, became disorganized after a very short time of exposure to microgravity. This alteration affected many genes involved in the regulation of cancer cell proliferation, susceptibility to drugs [<xref ref-type="bibr" rid="CR7">7</xref>], DNA repair (e.g. PARP), cell damage and invasion [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. However, to date the results of microgravity effects on cancer cells are contradictory mainly due to different setups, experimental designs and time points analyzed.</p>
              <p id="Par20">Given the difficulty of exposing cells and organisms to the real absence of gravity, many experiments are conducted on Earth, using tools that simulate the reduction of the gravity vector. The 3-Dimensional clinostat, Random Positioning Machine (RPM) is one of the most useful devices in this perspective. It simulates some of the physical effects of spaceflight by providing a gravity vector average reduction (down to 10<sup>−6</sup> g) of the apparent force of gravity, without generating significant shear forces [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
              <p id="Par21">Exploiting the RPM tool, we decided to perform a comprehensive analysis of the long-term effects of simulated microgravity (SMG) on pancreatic ductal adenocarcinoma (PDAC) cells. Despite its incisiveness, PDAC has not been examined so far in microgravity conditions. This neoplasia is one of the most severe malignancies, representing the 4<sup>th</sup>-5<sup>th</sup> cause of death from cancer in the western world. The therapeutic option currently available for PDAC is surgery, alone or in combination with radio or chemotherapy; however, only 8% of patients remain alive 5 years after diagnosis due to late diagnosis and/or resistance to the treatments. It is largely accepted that resistance to conventional anti-cancer treatments is due to a small cell subset called cancer stem cells (CSCs). CSCs are the main orchestrators of tumor establishment, metastatic progression and relapse. Already identified in most of the neoplastic tissues, differently from other tumor cells, CSCs are endowed with great plasticity, capability to enter quiescence and survive to microenvironment changes adapting metabolism, energy machinery and proliferation.</p>
              <p id="Par22">Performing a comprehensive transcriptomic, proteomic and lipidomic analysis in PDAC cells exposed for different time points to SMG, we demonstrated that microgravity induces cell transformation towards the acquisition of cancer stem cell-like features, leading to a more aggressive and metastatic phenotype.</p>
            </sec>
            <sec id="Sec2">
              <title>Materials and methods</title>
              <sec id="Sec3">
                <title>Cell cultures</title>
                <p id="Par23">Human ductal pancreatic adenocarcinoma cell lines PaCa-44 and CFPAC-1 were grown in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), 1% penicillin and streptomycin (PS). Human ductal pancreatic adenocarcinoma cell line AsPC-1 was grown in DMEM medium supplemented with 10% fetal bovine serum (FBS), 1% penicillin and streptomycin (PS). Cells were plated at the final concentration of 5 × 10<sup>5</sup> cells/ml on flask, Petri dish or flask on slide, according to the experimental design, and maintained at 37 °C with 5% CO<sub>2</sub>.</p>
                <p id="Par24">For simulated microgravity (SMG) cell culture 5 × 10<sup>5</sup> cells/ml were seeded in slide flasks and subsequently fitted onto a Random Positioning Machine (RPM, Dutch Space, NL), where they were kept under continuous rotation at 56 deg/s and at the temperature of 37 °C, for 1, 7 or 9 days. To avoid air bubbles formation and to ensure a minimization of turbulence and shear stress, flasks were completely filled with medium [<xref ref-type="bibr" rid="CR9">9</xref>]. Flasks were placed close to the support center to minimize any centrifugal acceleration, using “real random mode”. In this manner, speed and direction of the two rotating frames, changed randomly under the control of a software [<xref ref-type="bibr" rid="CR10">10</xref>].</p>
                <p id="Par25">For 3D culture, PaCa-44 cells were seeded onto U-bottom low adhesion 96 well-plates (Greiner Bio-One) at a concentration of 5 × 10<sup>4</sup> cells/well in 100 μl RPMI-1640 complete medium supplemented with 0,5% methyl-cellulose (spheroid-forming medium). Spheroids were grown at 37 °C and 5% CO<sub>2</sub>. Cells subjected to SMG were compared to two different control groups: frame controls and ground controls. Frame control cells (F, 1xg) were placed on the frame supporting the RPM in order to expose them to any vibration eventually produced and transmitted by the rotating machinery to the supporting structure. Ground control cells (1 g) both in spheroid-forming culture condition (Spheroid 1 g) and normal adhesion (Adhesion) were kept in an incubator at 37 °C and 5% CO<sub>2</sub>. Controls were analyzed at the same time points of SMG-cells.</p>
              </sec>
              <sec id="Sec4">
                <title>Spheroid staining and immunofluorescence</title>
                <p id="Par26">Spheroids were fixed in 4% PFA, dehydrated and embedded in London Resin White. Spheroids’ Sects. (1 μm thickness) were stained with toluidine blue and morphologically analyzed using an optic microscope (Zeiss Axiovert 100 M, Oberkochen, Germany).</p>
                <p id="Par27">For Calcein/PI staining, unfixed spheroids were stained with Calcein-AM (1 mM) for 20 min, followed by staining with PI (0.4 mg/ml) for 5 min. Then, spheroids were washed twice in PBS solution (0.1 M, pH 7.2) and observed at a fluorescent microscope (Axiovert 100 M, Zeiss). Fluorescent images were captured using AxioObserver Z2 inverted microscope (Zeiss), with Apotome2 system (Zeiss) and ZEN Blue 2.6 image acquisition software (Zeiss).</p>
              </sec>
              <sec id="Sec5">
                <title>Proteomic analysis</title>
                <p id="Par28">At different time points (according to the experimental setting), the cells were collected, washed in PBS and resuspended in RIPA buffer (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with protease inhibitors cocktail 1X (Roche, Basilea, Switzerland). To increase yields, cells were sonicated twice for 10 min; the lysate was gently mixed for 15 min on ice and then centrifuge at 14,000×<italic>g</italic> for 15 min at 4 °C to pellet the cell debris. Protein concentration was measured with BCA Protein Assay (Thermo Fisher Scientific) using bovine serum albumin as a standard. The cell lysates were reduced using 2.5 μL of dithiothreitol (200 mM DTT stock solution) (Sigma-Aldrich, St.Louis, MO, USA) at 90 °C for 20 min, and alkylated with 10 μl of Cysteine Blocking Reagent (Iodoacetamide, IAM, 200 mM Sigma-Aldrich) for 1 h at room temperature in the dark. Trypsin (Promega, Sequence Grade) was added and digestion was performed overnight at 37 °C. Then, the peptides digests were desalinated on the Discovery® DSC-18 solid phase extraction (SPE) 96-well Plate (25 mg/well) (Sigma-Aldrich) and the samples were ready for the analysis.</p>
                <p id="Par29">LC–MS/MS analyses were performed using a micro-LC Eksigent Technologies (Dublin, CA, USA) system with a stationary phase of a Halo Fused C18 column (0.5 × 100 mm, 2.7 μm; Eksigent Technologies). The mobile phase was a mixture of 0.1% (v/v) formic acid in water (A) and 0.1% (v/v) formic acid in acetonitrile (B), eluting at a flow-rate of 15.0μL min − 1 at an increasing concentration of solvent B from 2 to 40% in 30 min. The samples used to generate the SWATH-MS (Sequential window acquisition of all theoretical mass spectra) spectral library were subjected to the traditional data-dependent acquisition (DDA): the mass spectrometer analysis was performed using a mass range of 100–1500 Da (TOF scan with an accumulation time of 0.25 s), followed by a MS/MS product ion scan from 200 to 1250 Da (accumulation time of 5.0 ms) with the abundance threshold set at 30 cps (35 candidate ions can be monitored during every cycle). Samples were then subjected to cyclic data independent analysis (DIA) of the mass spectra, using a 25-Da window. A 50-ms survey scan (TOF–MS) was performed, followed by MS/MS experiments on all precursors. These MS/MS experiments were performed in a cyclic manner using an accumulation time of 40 ms per 25-Da swath (36 swaths in total) for a total cycle time of 1.5408 s. The ions were fragmented for each MS/MS experiment in the collision cell using the rolling collision energy. The MS data were acquired with Analyst TF 1.7 (AB SCIEX, Concord, Canada). Three instrumental replicates for each sample were subjected to the DIA analysis.</p>
                <p id="Par30">The mass spectrometry files were searched using Protein Pilot (AB SCIEX) and Mascot (Matrix Science Inc., Boston, USA). Samples were input in the Protein Pilot software v. 4.2 (AB SCIEX), with the following parameters: cysteine alkylation, digestion by trypsin, no special factors and False Discovery Rate at 1%. The UniProt Swiss-Prot reviewed database containing human proteins (version 12/10/2018, containing 48,561 sequence entries). The Mascot search was performed on Mascot v. 2.4, the digestion enzyme selected was trypsin, with 2 missed cleavages and a search tolerance of 50 ppm was specified for the peptide mass tolerance, and 0.1 Da for the MS/MS tolerance. The charges of the peptides to search for were set to 2 + , 3 + and 4 + , and the search was set on monoisotopic mass. The instrument was set to ESI-QUAD-TOF and the following modifications were specified for the search: carbamidomethyl cysteine as fixed modification and oxidized methionine as variable modification [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p>
                <p id="Par31">The quantification was performed by integrating the extracted ion chromatogram of all the unique ions for a given peptide. The quantification was carried out with PeakView 2.0 and MarkerView 1.2. (AB SCIEX). Six peptides per protein and six transitions per peptide were extracted from the SWATH files. Shared peptides were excluded as well as peptides with modifications. Peptides with FDR lower than 1.0% were exported in MarkerView for the t-test.</p>
                <p id="Par32">Ingenuity Pathways Analysis (IPA) software (Qiagen, Redwood City, CA, USA) and STRING software (<ext-link ext-link-type="uri" xlink:href="http://www.stringdb.org">www.stringdb.org</ext-link>), were used for bioinformatics analysis [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
              </sec>
              <sec id="Sec6">
                <title>Lipidomic analysis</title>
                <p id="Par33">Cells were extracted using a solution 75:15 IPA/H<sub>2</sub>O, after the addition of 100μL of MeOH 5% deuterated standard (Splash Lipidomix®). Then the samples were vortexed for 30 s, sonicated for 2 min and vortexed again for 30 s and then they were incubated for 30 min at 4 °C, under a gentle, constant shaking. Another 30 min were used to keep the sample rest in ice. To remove debris and other impurities, the samples were centrifuged for 10 min at 3500<italic>g</italic> at 4 °C. 1 mL of supernatant was collected and dried using a SpeedVac. The dried samples were reconstituted in 100μL of MeOH containing the internal standard CUDA (12.5 ng/mL).</p>
                <p id="Par34">For the analysis of the reconstituted lipids a UHPLC Vanquish system (Thermo Scientific, Rodano, Italy) coupled with an Orbitrap Q-Exactive Plus (Thermo Scientific) was used. A reverse phase column was used for the separation of lipids (Hypersil Gold™ 150 × 2.1 mm, particle size 1.9 µm), the column was maintained at 45 °C at a flow rate of 0.260 mL/min. Mobile phase A for the ESI positive mode consisted of acetonitrile/water 60:40 (v/v) while B was isopropanol/acetonitrile 90:10 (v/v) both modified with ammonium formate (10 mM) and 0.1% formic acid while in the negative ESI mode the same organic solvents and same proportioning were used, except for the use of ammonium acetate (10 mM) as mobile-phase modifier instead of ammonium formate. The gradient used was as follows: 0–2 min from 30 to 43% B, 2–2.1 min from 43 to 55% B, 2.1–12 min from 55 to 65% B, 12–18 min from 65 to 85% B, 18–20 min from 85 to 100% B; 100% B was kept for 5 min and then the column was allowed to re-equilibrate at 30% B for another 5 min. The total run time was 30 min.</p>
                <p id="Par35">Mass spectrometry analysis was performed in both positive and negative ion mode. The source voltage was maintained at 3.5 kV in the positive ion mode and 2.8 kV in the negative ion mode. All other interface settings were identical for the two types of analysis. The capillary temperature, sheath gas flow, and auxiliary gas flow were set at 320 °C, 40 arb, and 3 arb respectively. S-lens was settled at 50 rf. Data were collected in a data-dependent (ddMS2) top 10 scan mode. Survey full-scan MS spectra (mass range m/z 80 to 1200) were acquired with resolution <italic>R</italic> = 70,000 and AGC target 1 × 106. MS/MS fragmentation was performed using high-energy c-trap dissociation (HCD) with resolution <italic>R</italic> = 17,500 and AGC target 1 × 105. The stepped normalized collision energy (NCE) was set to 15, 30, and 45, respectively. The injection volume was 3µL. Lockmass and regular inter-run calibrations were used for accurate mass-based analysis. An exclusion list for background ions was generated analysing the same procedural blank sample, both for the positive and negative ESI mode.</p>
                <p id="Par36">The acquired raw data from the untargeted analysis were processed using MSDIAL software (Yokohama City, Kanagawa, Japan), version 4.24. This included the detection of peaks, MS2 data deconvolution, compound identification, and the alignment of peaks through all the samples.</p>
                <p id="Par37">For identification a cut off value of 85% was selected: this value is based on 6 different similarity scores: 1 for retention time, 1 for m/z 1 for isotopic pattern, and 3 for MS/MS (dot product, dot product reversed and presence). The dataset containing m/z values, retention time, peak area, and annotation from the aligned files were exported as an Excel file and manually checked in order to eliminate signals from blanks or wrong records.</p>
                <p id="Par38">For quantification, the peak area for different detected molecular species for each particular lipid was combined (e.g., [M + NH4] + &amp; [M + Na] + for TG) followed by normalization using the deuterated internal standard for each lipid class. In order to obtain an estimated concentration expressed in ug/mL the normalized areas were multiplied by the concentration of the internal standard. An in-house library of standards was also used for lipids identification. MetaboAnalyst 4.0 software (<ext-link ext-link-type="uri" xlink:href="http://www.metaboanalyst.org">www.metaboanalyst.org</ext-link>) was used for statistical analysis [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
              </sec>
              <sec id="Sec7">
                <title>Spheroid migration assay</title>
                <p id="Par39">96-well flat-bottomed plates were coated with 50ul/well of gelatin 0.1% (v/v) in sterile ddH2O. The plate was incubated at room temperature for 2 h; then the residual of gelatin was aspirated. The wells were washed twice with PBS and 100ul of 1% (w/v) BSA (Sigma Aldrich) in PBS was added for 1 h at room temperature. Residual BSA was aspirate and one single spheroid was plated in each well in 200ul of complete culture medium (RPMI-1640). The plate was then transferred for 30 min in the incubator to allow spheroids to adhere to the coated surface before imaging for the <italic>t</italic> = 0 time point. Pictures were analyzed using Image-Pro premier software and the migration capability was evaluated as the delta volume compared to the spheroid at T0.</p>
              </sec>
              <sec id="Sec8">
                <title>FACS sorting</title>
                <p id="Par40">PaCa-44 cells were stained with Live/Dead fixable dye (1:1000; ThermoFisher) and anti-human EpCAM (1:100, BD, Franklin Lakes, NJ, USA) for 30 min at + 4 °C. After washed in MACS buffer, cells were FACS-sorted with a MoFlo Astrios Cell Sorter (Beckman Coulter, Brea, CA); the purity of the sorted populations always exceeded 90%.</p>
              </sec>
              <sec id="Sec9">
                <title>Lactate dehydrogenase (LDH) assay</title>
                <p id="Par41">To evaluate LDH enzyme activity the CyQUANT™ LDH cytotoxicity assay kit (Invitrogen, Thermo Fisher Scientific) was used according to the manufacturer’s instructions. 50 µL of supernatant was collected from cells cultured in the different culture conditions (normal adhesion, spheroid at 1 g and simulated microgravity, SMG) at the end of each experiment and dispensed into a new 96-well plate (Thermo Fisher Scientific). LDH activity was quantified with Tecan Infinite F200Pro plate reader (Tecan, Austria) at 490 nm absorption.</p>
              </sec>
              <sec id="Sec10">
                <title>Cell proliferation MTT assay</title>
                <p id="Par42">10<sup>5</sup> cells were seeded in 100ul of complete culture medium (RPMI-1640) in 96 well flat-bottomed plates. For proliferation analysis in PaCa-44 cells grown in adhesion culture condition, the cells were allowed to adhere to the plate o/n in the incubator. 10 μl of MTT solution (final concentration 0.5 mg/ml) was added to each well and the plate transferred for 4 h in the incubator. The reaction was then stopped adding 100 μl/well of solubilization solution (12 M HCl, isopropanol and TritonX 10%). After 15 min in the incubator, the absorbance of the samples was measured using a microplate reader at the wavelength of 570 nm. Results were presented as delta absorbance between the samples and the blank condition.</p>
              </sec>
              <sec id="Sec11">
                <title>TUNEL assay</title>
                <p id="Par43">Apoptosis was evaluated using the In Situ Cell Death Detection Kit, Fluorescein (Roche, Lewes, UK) in the spheroids obtained in SMG. Spheroids were fixed in PFA 4%, embedded in Technovit 8100 resin (BioOptica, Milan, Italy) and sectioned. Sections were permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate and exposed to TUNEL reaction mixture for 1 h at 37 °C, in a humidified atmosphere, protected from light. After PBS washes, sections were analyzed with AxioObserver Z2 inverted microscope (Zeiss), with Apotome2 system (Zeiss) and ZEN Blue 2.6 image acquisition software (Zeiss).</p>
                <sec id="Sec12">
                  <title>Western Blot analysis</title>
                  <p id="Par44">After 9 days of maintenance in the different culture conditions (adhesion, spheroid at 1 g and simulated microgravity), cells were collected and lysed with RIPA buffer supplemented with protease and phosphatase inhibitors (PPC1010, Sigma-Aldrich, Milan, Italy). The protein concentration was determined using BCA protein assay (71,285, Sigma-Aldrich, Milan, Italy) and equal amounts of protein were loaded on NuPAGE™ 4–12% Bis–Tris protein precast polyacrylamide gels (Invitrogen, Thermo Fisher Scientific) in denaturing and reducing conditions. After transfection into nitrocellulose membranes (Perkin Elmer), membranes were saturated with 5% non-fat milk in TBS- 0.1% Tween 20 buffer, and hybridized overnight at 4 °C with the following primary anti-human antibodies: rabbit anti-N-cadherin (1:3000<bold>,</bold> Genetex, Irvine, CA), rabbit anti-E-cadherin (1:3000<bold>,</bold> Genetex), rabbit anti-NF-kB p50 (1:1000, Santa Cruz), rabbit anti-NF-kB p65 (1:1000, Santa Cruz), rabbit anti-phopsho-NF-kB p65 (Ser536, 1:1000, Cell Signaling, Boston, MD), mouse anti-Epcam (1:1000, Cell Signaling), mouse anti-GAPDH (1:1000, Santa Cruz), mouse anti-α-Tubulin (1:1000, Merckmillipore), mouse anti-β-Actin (1:1000, Cell Signaling), rabbit anti-LDHA (1:2000, Cell signaling) and mouse anti-Nanog (1:1000, Biorbyt, Cambridge, UK). Membranes were then washed and probed for 1 h at room temperature with HRP-conjugated secondary antibodies and developed using chemiluminescence reagents (SuperSignal™ West Pico PLUS Chemiluminescent Substrate, 34,580, Thermo Fisher Scientific). Membranes were scanned using a ChemiDoc™ XRS Imaging System (Bio-Rad, Hercules, CA) and bands were quantified using NIH Image J software (Version 1.53f51, National Institutes of Health (NIH), Bethesda, MA, USA).</p>
                </sec>
              </sec>
              <sec id="Sec13">
                <title>RNA extraction and qRT-PCR</title>
                <p id="Par45">Total RNA was extracted, using TRIzol Reagent (Thermo Fisher Scientific), from PaCa-44 cells cultured under all the different culture conditions. 1 μg of RNA was reverse transcribed using first-strand cDNA synthesis. Real-time qPCR quantification was performed in triplicate samples by SYBR-Green detection chemistry with GoTaq qPCR Master Mix (Promega, Madison, WI, USA) with a QuantStudio 3 Real-Time PCR System (Thermo Fisher Scientific, USA). The primers used are listed in Table <xref rid="Tab1" ref-type="table">1</xref>. The cycling conditions used were: 95 °C for 10 min, 40 cycles at 95 °C for 15 s, 60 °C for 1 min, 95 °C for 15 s, and 60 °C for 15 s. The average of the cycle threshold of each triplicate was analyzed according to the 2<sup>−ΔΔCt</sup> method. 18S gene expression was used as endogenous control to standardize mRNA expression.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Sequences of primers used for qPCR analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">GENES</th><th align="left">FORWARD PRIMER SEQUENCE</th><th align="left">REVERSE PRIMER SEQUENCE</th></tr></thead><tbody><tr><td align="left">CDH1</td><td align="left">5′-GACACCAACGATAATCCTCCGA-3′</td><td align="left">5’-GGCACCTGACCCTTGTACGT-3’</td></tr><tr><td align="left">ZEB1</td><td align="left">5′-GTTACCAGGGAGGAGCAGTGAAA-3′</td><td align="left">5′-GACAGCAGTGTCTTGTTGTTGTAGAAA-3′</td></tr><tr><td align="left">EpCAM</td><td align="left">5'-CCGCTGCGAGGACGTAGA-3'</td><td align="left">5'-TGTTGGCTGCGTCTCATCAAACC-3'</td></tr><tr><td align="left">CASP 3</td><td align="left">5’-CTGGTTTTCGGTGGGTGT-3’</td><td align="left">5’-CACTGAGTTTTCAGTGTTCTCCA-3’</td></tr><tr><td align="left">CASP 8</td><td align="left">5’-CAGCAGCCTTGAAGGAAGTC-3’</td><td align="left">5’-CGAGATTGTCATTACCCCACA-3’</td></tr><tr><td align="left">CASP 9</td><td align="left">5’-CCCAAGCTCTTTTTCATCCA-3’</td><td align="left">5’-AGTGGAGGCCACCTCAAAC-3’</td></tr><tr><td align="left">BAD</td><td align="left">5’-ACCAGCAGCAGCCATCAT-3’</td><td align="left">5’-GGTAGGAGCTGTGGCGACT-3’</td></tr><tr><td align="left">TRAIL</td><td align="left">5’-CCTCAGAGAGTAGCAGCTCACA-3’</td><td align="left">5’-CAGAGCCTTTTCATTCTTGGA-3’</td></tr><tr><td align="left">BAX</td><td align="left">5’-CAAGACCAGGGTGGTTGG-3’</td><td align="left">5’-CACTCCCGCCACAAAGAT-3’</td></tr><tr><td align="left">N-CDH</td><td align="left">5’-CCTCCAGAGTTTACTGCCATGAC-3’</td><td align="left">5’-GTAGGATCTCCGCCACTGATTC-3’</td></tr><tr><td align="left">OCT4</td><td align="left">5′-GACAG GGGGAGGGGAGGAGCTAGG-3′</td><td align="left">5′-CTTCCCTCCAACCAGTTGCCCCAAAC-3</td></tr><tr><td align="left">NANOG</td><td align="left">5′-AGTCCCAAAGGCAAACAACCCACTTC-3′</td><td align="left">5′-TGCTGGAGGCTGAGGTATTTCTGTCTC-3′</td></tr><tr><td align="left">SOX2</td><td align="left">5′-GGGAAATGGGAGGGGTGCAAAAGAGG-3′</td><td align="left">5′-TTGCGTGAGTGTGGATGGGATTGGTG-3′</td></tr><tr><td align="left">18S</td><td align="left">5’-ACTTTCGATGGTAGTCGCCGT-3’</td><td align="left">5’-CCTTGGATGTGGTAGCCGTTT-3’</td></tr><tr><td align="left">GAPDH</td><td align="left">5′-ATCAGCAATGCCTCCTGCAC-3′</td><td align="left">5′-TGGTCATGAGTCCTTCCACG-3′</td></tr></tbody></table></table-wrap></p>
              </sec>
              <sec id="Sec14">
                <title>Statistical analysis</title>
                <p id="Par46">Values were expressed as mean ± s.e.m. Either one-way ANOVA or two-tailed, unpaired Student’s <italic>t</italic>-test was used to compare unmatched groups with Gaussian distribution. A Mann–Whitney <italic>U</italic>-test was used in cases of non-Gaussian distribution. Two-way ANOVA corrected for multiple comparison tests was used to take into account multiple comparisons. P ≤ 0.05 was considered statistically significant. Statistical analyses were performed with GraphPad Prism v.7 GraphPad Software.</p>
              </sec>
            </sec>
            <sec id="Sec15">
              <title>Results</title>
              <sec id="Sec16">
                <title>Simulated microgravity alters the proteomic profile of PaCa-44 cells in a time-dependent manner</title>
                <p id="Par47">To investigate the effects of microgravity on PDAC, PaCa-44 cells were plated in complete medium in uncoated flasks and cultured at 1 g (as control, Adhesion) or in RPM (SMG); in parallel some cells were plated in spheroid-forming medium in u-bottom low adhesion 96 well-plates at 1 g (Spheroids 1 g, Fig. <xref rid="Fig1" ref-type="fig">1</xref>A). While in Adhesion the cells maintained their shape along all the evaluated time points, after 24 h (T1), both in 1 g spheroid-forming and SMG conditions, the cells underwent spontaneous aggregation forming small and loose tridimensional structures (Fig. <xref rid="Fig1" ref-type="fig">1</xref>A). These aggregates began to form spherical-like structures with a diameter around 100 µm that grew over 1 mm from the 7th to the 9th day (T7 and T9 respectively; Fig. <xref rid="Fig1" ref-type="fig">1</xref>A) in SMG, whereas in normal gravity they remained around 100 µm of diameter over time (Fig. <xref rid="Fig1" ref-type="fig">1</xref>A). When stained with Calcein-PI, spheroids obtained from SMG culture condition revealed an inner necrotic core of dead cells surrounded by vital cells accumulated in the outer layer (Fig. <xref rid="Fig1" ref-type="fig">1</xref>B). Similar results were obtained in other two pancreatic cancer cell lines, CFPAC-1 and AsPC-1, maintained in the same culture conditions: 9 days of SMG exposure was associated with a morphological rearrangement of the cells that grown as compact and large 3D spheres (Suppl. Fig S1, panel A and D).<fig id="Fig1"><label>Fig. 1</label><caption><p>Simulated microgravity (SMG) alters the proteomic profile of PaCa-44 cells in a time-dependent manner. <bold>A</bold> PaCa-44 cells were cultured in adhesion condition at 1 g (Adhesion) or in SMG, and in spheroid-forming culture condition at normal gravity (Spheroid 1 g). Representative pictures acquired at 1, 7 and 9 days of culture (T1, T7 and T9, respectively); scale bar 400 μm for Adhesion, 200 μm for Spheroids 1 g and SMG pictures. <bold>B</bold> Calcein/PI staining on spheroids obtained after 1, 7 and 9 days in SMG culture conditions (T1, T7 and T9 SMG, respectively). Scale bar 100 μm. <bold>C</bold> Canonical pathways modulated by differentially expressed proteins after 1, 7 or 9 days of SMG (T1, T7 and T9 SMG respectively). The pathways are indicated in the y-axis. On the x-axis, the z-score for each pathway calculated in comparison to the adhesion culture condition. Orange bars predict an overall increase in the pathway activity, while blue bars predict a decrease. <bold>D</bold> Heat-map of z-score of the canonical pathways modulated in all of the three different time points presented in panel C (1, 7 and 9 days in SMG)</p></caption><graphic xlink:href="18_2022_4243_Fig1_HTML" id="MO1"/></fig></p>
                <p id="Par48">To investigate the biological alterations induced by SMG exposure, PaCa-44 cells were cultured in RPM or in normal culture conditions (Adhesion 1 g, as control) in the same plastic supports, same medium, and at the same concentration (as detailed in the Methods section). At different time points (1, 7 and 9 days) a large proteomic analysis was performed with SWATH-MS using a statistical cut-off of <italic>p</italic>-value &lt; 0.05 and fold change &gt; 1.3. Results showed that 24 h of SMG induced the modulation of 360 proteins (206 up and 154 downregulated, compared to control culture condition). On the 7th day in SMG condition, cells upregulated 128 proteins and downregulated 111 (for a total of 239 proteins), whereas on the 9th day in SMG 335 proteins were modulated, of whom 208 upregulated and 127 downregulated.</p>
                <p id="Par49">The proteomic data set, including UniProt code and fold changes, was then uploaded to Ingenuity Pathway Analysis (IPA) bioinformatics tool, to identify the canonical pathways significantly modulated. After 24 h in SMG, 34 canonical pathways were upregulated (z-score &gt; 0) and 21 downregulated (z-score &lt; 0; Fig. <xref rid="Fig1" ref-type="fig">1</xref>C, T1 SMG); 10 pathways, instead, presented a modulation of protein expression but the final z-score was 0. After 7 days, 27 pathways were upregulated (z-score &gt; 0), 18 downregulated (z-score &lt; 0) and 5 presented z-score = 0 (Fig. <xref rid="Fig1" ref-type="fig">1</xref>C, T7 SMG). On the day 9 in SMG, 59 pathways were upregulated (z-score &gt; 0), 14 downregulated (z-score &lt; 0) and 6 presented a z-score = 0 (Fig. <xref rid="Fig1" ref-type="fig">1</xref>C, T9 SMG). Evaluating only the pathways enriched at all the three time points, we discovered that most of the upregulated pathways were involved in cell cytoskeletal modification such as <italic>Integrin signaling</italic>, <italic>ILK signaling</italic>, <italic>Regulation of actin-based motility by Rho</italic>, <italic>RhoA signaling</italic>, <italic>Signaling by Rho Family GTPase</italic> and <italic>Actin cytoskeleton signaling</italic> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>D). These results clearly support the effect of SMG in cellular reorganization.</p>
              </sec>
              <sec id="Sec17">
                <title>Exposure to simulated microgravity is associated with cytoskeletal reorganization and increased migration capability</title>
                <p id="Par50">One of the protein pathways most altered by SMG exposure is the “<italic>Regulation of actin-based motility by Rho</italic>”. RhoA signaling is involved in cytoskeleton reorganization, which induces actin migration toward the external plasma membrane where it participates in the formation of membrane blebs, thus promoting cell migration [<xref ref-type="bibr" rid="CR15">15</xref>]. Proteomic analysis indicated a time-dependent upregulation of the pathway, from 24 h up to 9 days in SMG (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A). Cdc42 signaling, which belongs to the Rho family of GTPase, contributes to the cytoskeletal organization throughout the perturbation of actin polymerization, as well as in the formation of actin bundle-containing filopodia at the cellular surface. Our results indicated that, as for RhoA, Cdc42 pathway was upregulated by SMG at all the 3 time points evaluated (Fig. <xref rid="Fig2" ref-type="fig">2</xref>B).<fig id="Fig2"><label>Fig. 2</label><caption><p>Exposure to simulated microgravity (SMG) is associated with cytoskeletal reorganization and increased migration capability. <bold>A–B</bold> Average logarithmic fold change of proteins involved in the Actin-based motility by Rho signaling (<bold>A</bold>) and Cdc42 signaling (B) evaluated in PaCa-44 cells maintained in SMG for 1, 7 or 9 days (T1, T7 and T9 SMG, respectively); in green proteins downregulated while in red proteins upregulated compared to adhesion culture conditions. <bold>C–E</bold> Average logarithmic fold change of proteins involved in the cytoskeletal and nuclear reorganization, evaluated in PaCa-44 cells maintained in SMG for 1 (<bold>C</bold>), 7 (<bold>D</bold>) or 9 (<bold>E)</bold> days; in green proteins downregulated while in red proteins upregulated compared to adhesion culture conditions at 1 g. <bold>F</bold> Representative pictures of Toluidine blue staining in semithin sections of spheroids obtained after 7 or 9 days in simulated microgravity (SMG); scale bar 10 μm. <bold>G–H</bold> Average logarithmic fold change of proteins involved in the leukocyte extravasation (<bold>G</bold>) and ILK (<bold>H</bold>) signaling evaluated in PaCa-44 cells maintained in SMG for 1 (<bold>A</bold>), 7 (<bold>B</bold>) or 9 (<bold>C</bold>) days (T1, T7 and T9 SMG, respectively); in green proteins downregulated while in red proteins upregulated compared to adhesion culture conditions. <bold>I</bold> qRT-PCR analysis of EMT-associated markers in PaCa-44 cells maintained in normal culture condition (Adhesion) or in simulated microgravity (SMG) for 1, 7 or 9 days (T1, T7 and T9 SMG, respectively). Data are expressed as mean ± sem of n = 3 replicates. *0.05, ***0.0002 and **** &lt; 0.0001. <bold>L</bold> Western blot analysis of CDH-1 and N-CDH1 on PaCa-44 cells maintained in normal culture condition (Adhesion), spheroid-forming condition at 1 g (Spheroid 1 g) or in simulated microgravity (SMG) for 9 days; Tubulin is used as housekeeping. <bold>M</bold> Migration capability of spheroids collected on the 9th day from SMG culture or 1 g spheroid culture (Spheroid 1 g). On the left representative pictures of spheres at the different time points after seeding; on the right the graph with the mean ± sem migration calculated as spheres’ circumference at each time point compared to T0 (Delta)</p></caption><graphic xlink:href="18_2022_4243_Fig2_HTML" id="MO2"/></fig></p>
                <p id="Par51">After 24 h in SMG, tubulin expression was upregulated (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C); actin upregulation, instead, was evident only at longer exposure time, from 7 up to 9 days, when keratin's upregulation was massive (Fig. <xref rid="Fig2" ref-type="fig">2</xref>D, <xref rid="Fig2" ref-type="fig">E</xref>). Interestingly, lamin A and B (LMNA and LMNB2, respectively), involved in oxidative stress resistance [<xref ref-type="bibr" rid="CR16">16</xref>], were downregulated by SMG already after 24 h up to 9 days (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C–E). In addition, 9 days of SMG exposure was associated with upregulation of E-cadherin (CDH1) and integrins (ITGA3, ITGB1 and ITGA6) that play a key role in cell adhesion to the extracellular matrix (substrate). In line, at the same time point (T9), we observed an increment of cell migration from the spheroidal structures to the flask where cells adhere to the surface (data not shown). The over time upregulation of keratins and integrins could be associated with increased cell aggregation and spheroid formation. Indeed, while after 24 h cells were mainly organized in weakened aggregates, after 7 days in SMG cells formed spheroidal structures already compact that progressively grew (up to 9 days) as demonstrated by blue toluidine staining (Fig. <xref rid="Fig2" ref-type="fig">2</xref>F). The spheroids appeared to be constituted by an outer shell of cells exhibiting extensive cell-to-cell adhesion, and an inner necrotic core (Fig. <xref rid="Fig2" ref-type="fig">2</xref>F). Such morphological changes are crucial for cell migration and metastatic potential. In line, “<italic>Leukocytes extravasation signaling</italic>” was altered in all the evaluated time points. Interestingly, on the 1st day in SMG the pathway was inhibited (Fig. <xref rid="Fig2" ref-type="fig">2</xref>G, T1 SMG) while after 7 days it was activated and remained active up to the 9th day (Fig. <xref rid="Fig2" ref-type="fig">2</xref>G). The upregulation of <italic>“Actin-based motility by RhoA signaling”</italic>, “<italic>Leukocytes extravasation signaling</italic>” and “<italic>ILK signaling”</italic> at all the analyzed time points (Fig. <xref rid="Fig2" ref-type="fig">2</xref>H) suggests the capability of PaCa-44 cells to adhere to the endothelium and migrate in SMG conditions. To confirm the impact of SMG on cell migration, we analyzed the expression levels of genes regulating the epithelial-to-mesenchymal transition (EMT) process at 1, 7 and 9 days of SMG exposure. EMT regulates morphological changes in tumor cells inducing the acquisition of a mesenchymal phenotype, rather than epithelial, thus supporting migration and spreading of cancer cells. qRT-PCR analysis indicated increased expression of N-cadherin (N-CDH), Vimentin and Zeb1 (mesenchymal markers), and matrix-metallopeptidase-7 (MMP-7) in PaCa-44 cells under SMG, particularly evident on the 9th day (F<xref rid="Fig2" ref-type="fig">i</xref>g. <xref rid="Fig2" ref-type="fig">2</xref>I), compared to cells maintained in normal gravity adhesion condition. Modulation of E-cadherin (CDH-1) and N-CDH1 expression in PaCA-44 cells after 9 days of exposure to SMG was also confirmed by Western blot analysis (Fig. <xref rid="Fig2" ref-type="fig">2</xref>L). Similar results were obtained in CFPAC-1 and AsPC-1 cells: both lines showed downregulation of CDH-1 (Suppl. Fig. S1, panel B and E) and upregulation of Zeb-1 and N-CDH after 9 days in SMG (Suppl. Fig. S1, panel B, C, E, F). In addition, we performed a spheroid-migration assay comparing spheroids obtained from PaCa-44 cells maintained in SMG or spheroid-culture condition at 1 g (Spheroid 1 g) for 9 days. The results showed higher migration capability of tumor cells exposed to SMG (Fig. <xref rid="Fig2" ref-type="fig">2</xref>M) confirming the regulation of cell mobilization mediated by altered gravity.</p>
              </sec>
              <sec id="Sec18">
                <title>Simulated microgravity triggers cancer stem cell selection</title>
                <p id="Par52">It has been largely demonstrated that the ability to form spheroids and migrate is related to the acquisition of a stemness phenotype. To further confirm that SMG exposure induces stemness enrichment, we evaluated the expression of specific stemness-related master genes (Nanog, Sox2 and Oct4) in PaCa-44 cells maintained in the different culture conditions. As shown in Fig. 3A, 9 days in SMG induced a significantly increased expression of all the evaluated genes. These results suggest a key role of microgravity in time-dependent stemness regulation. In support, proteomic analysis indicated that IL-8 signaling, which is involved in stemness, neo-angiogenesis and EMT process regulation [<xref ref-type="bibr" rid="CR17">17</xref>], was upregulated after 9 days in SMG (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). ERK5 signaling, instead, was upregulated already after 24 h in SMG (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C). Interestingly, it has been reported that the activation of ERK5 pathway triggers the upregulation of IL-8 signaling and NF-κB transcriptional activity, suggesting an ERK5/NF-κB/IL-8 signaling axis involved in the regulation of stem cell malignancy [<xref ref-type="bibr" rid="CR18">18</xref>]. Proteomic analysis indicated that NF-κB signaling was upregulated on the 9th day in SMG (whereas after 1 and 7 days in SMG the pathway has a <italic>z</italic> -score = 0; Fig. <xref rid="Fig3" ref-type="fig">3</xref>D). In line, western blot evaluation of p50 and p65 NF-kB family members in PaCa-44 cells showed an evident induction of p65 expression and a concomitant inhibition of p50 expression after 9 days SMG, compared to cells maintained in normal adhesion culture condition (Adhesion) or spheroid-forming culture condition (Suppl. Fig. S2).<fig id="Fig3"><label>Fig. 3</label><caption><p>Simulated microgravity (SMG) triggers cancer stem cell selection. <bold>A</bold> qRT-PCR analysis of stemness-associated genes in PaCa-44 cells maintained in adhesion culture condition at normal gravity (Adhesion), altered gravity (SMG), or in spheroid-forming culture condition at normal gravity (Spheroid 1 g) for 1, 7 or 9 days. Data are expressed as mean ± sem of n = 3 replicates. * 0.05, ***0.0002 and **** &lt; 0.0001. <bold>B–C</bold> Average logarithmic fold change of proteins involved in IL-8 (<bold>B</bold>) and ERK5 signalings (<bold>C</bold>) evaluated in PaCa-44 cells maintained in SMG for 1, 7 or 9 days (T1, T7 and T9 SMG, respectively); in green proteins downregulated while in red proteins upregulated, compared to adhesion culture conditions. <bold>D</bold> Z-score of NF-κB pathway evaluated in PaCa-44 cells exposed to SMG for 1, 7 or 9 days. <bold>E</bold> Average logarithmic fold change of proteins related to stemness and epithelial-to-mesenchymal transition signaling in PaCa-44 cells maintained in SMG for 9 days. <bold>F</bold> qRT-PCR analysis of stemness genes in PaCa-44 cells grown in normal culture condition and FACS separated according to the expression of EpCAM. <bold>G</bold> qRT-PCR analysis of EpCAM expression in PaCa-44 cells maintained in Adhesion culture condition at 1 g or in SMG for 1, 7 or 9 days (T1, T7 and T9 SMG, respectively). Data are expressed as mean ± sem of n = 3 replicates. *0.05; **** &lt; 0.0001</p></caption><graphic xlink:href="18_2022_4243_Fig3_HTML" id="MO3"/></fig></p>
                <p id="Par53">At this time point (T9) stemness-related proteins such as EpCAM, ALDH1A3, ALDHA3A2, S100A4, ROHA, and ITGA3 (Fig. <xref rid="Fig3" ref-type="fig">3</xref>F) were upregulated, indicating a cellular reprogramming towards a more stem and aggressive phenotype. It has been demonstrated [<xref ref-type="bibr" rid="CR19">19</xref>] that EpCAM is a reliable marker for the identification of CSCs in various tumor types including pancreatic cancer. Indeed, when PaCa-44 cells were FACS sorted according to the expression of EpCAM, we observed a significantly higher expression of stemness-associated master genes (Nanog, Sox2 and Oct4) in EpCAM<sup>pos</sup> compared to EpCAM<sup>neg</sup> cells (Fig. <xref rid="Fig3" ref-type="fig">3</xref>G). Analysis of expression levels of EpCAM in PaCa-44 cells subjected to SMG indicated an over time increase of this marker, supporting our findings of a CSC enrichment mediated by altered gravity force (Fig. <xref rid="Fig3" ref-type="fig">3</xref>H).</p>
              </sec>
              <sec id="Sec19">
                <title>Simulated microgravity strongly edits cell metabolism</title>
                <p id="Par54">The morphological rearrangement (3D spheroids) induced by SMG also affected cellular nutrition and metabolism. From the proteomic analysis, it has emerged that eIF2 signaling was the most enriched pathway modulated by SMG (Fig. <xref rid="Fig4" ref-type="fig">4</xref>A-C). Compared to the control, the pathway was inhibited already after 24 h (Fig. <xref rid="Fig4" ref-type="fig">4</xref>A) and it was maintained downregulated up to 9 days in SMG (Fig. <xref rid="Fig4" ref-type="fig">4</xref>B, <xref rid="Fig4" ref-type="fig">C</xref>). eIF2 is a component of the translational machinery and plays a key role in the orchestration of protein synthesis. Repression of global protein synthesis (as in the case of eIF2 signaling inhibition) allows cells to conserve nutrients and energy for stress remediation. Indeed, it has been demonstrated that eIF2 signaling regulates autophagy and metabolism in order to maintain an energy balance in cancer cells. In line, our proteomic data revealed that glycolysis was downregulated after 24 h in SMG (as indicated by negative logFC of SLC2A1, LDH and ENO1; Fig. <xref rid="Fig4" ref-type="fig">4</xref>D, T1 SMG), but after 7 days was upregulated (positive logFC of ENO1, GAPDH, ALDOA, PGAM1, TPI1 and PKMI proteins; Fig. <xref rid="Fig4" ref-type="fig">4</xref>D, T7 SMG). The pathway remained upregulated on the 9th day (positive logFC of LDHA, GAPDH, PKM and SLC2A1 proteins; Fig. <xref rid="Fig4" ref-type="fig">4</xref>D, T9 SMG). In parallel, the analysis of extracellular lactate dehydrogenase (LDH) indicated a reduction of LDH levels after 1 day in SMG (compared to normal adhesion culture condition) and an increase on the 7th and 9th day in SMG (Fig. <xref rid="Fig4" ref-type="fig">4</xref>E) suggesting a metabolic switch of PaCa-44 cells under reduced gravity culture condition. Similar results were obtained in CFPAC-1 and AsPC-1 cells exposed to SMG. After 9 days both cell lines presented an upregulation of GAPDH and LDHA at mRNA and protein level compared to the same cells maintained in normal adhesion or spheroid-forming culturing condition in normal gravity (Suppl. Fig. S1, panel B, C, E and F).<fig id="Fig4"><label>Fig. 4</label><caption><p>Simulated microgravity (SMG) exposure edits tumor cell metabolism. <bold>A–C</bold> Heat map of eiF2-related protein fold change expression, evaluated in PaCa-44 cells maintained in SMG for 1 (<bold>A</bold>), 7 (<bold>B</bold>) or 9 (<bold>C</bold>) days; <bold>D</bold> Average logarithmic fold change of proteins involved in glycolysis evaluated in PaCa-44 cells maintained in SMG for 1, 7 or 9 days; in green proteins downregulated while in red proteins upregulated compared to adhesion culture conditions. <bold>E</bold> Extracellular levels of LDH evaluated at 1, 7 and 9 days (T1, T7 and T9, respectively) in PaCa-44 cells maintained in adhesion or spheroid-forming culture condition at normal gravity (Adhesion or Spheroid 1 g, respectively) and in SMG. <bold>F</bold> Average logarithmic fold change of proteins involved in HIF-1α signaling evaluated in PaCa-44 cells maintained in SMG for 1, 7 or 9 days; in green proteins downregulated while in red proteins upregulated compared to adhesion culture conditions. <bold>G</bold> Donut chart of the number of identified lipids for each class. <bold>H</bold> Hierarchical clustering heat-map of lipid expression evaluated in PaCa-44 cells maintained in Adhesion culture condition at 1 g or in SMG for 1, 7 or 9 days. <bold>I</bold> Total lipid concentration for triacylglycerols (TGs), lysophosphatidylcholine (LPCs), lysophosphatidylethanolamine (LPEs) and fatty acids (FAs) evaluated in PaCa-44 cells maintained in Adhesion culture condition at 1 g or in SMG for 1, 7 or 9 days. <bold>J–K</bold> Lipid concentration of unsaturated fatty acids (Fas, D), phosphatidylcholines (PC) and phosphatidylethanolamines (PE, E) evaluated in PaCa-44 cells maintained in Adhesion culture condition at 1 g or in SMG. <bold>L</bold> Ratio of long-intermediate-chain acylcarnitines (C16-C20) to short-chain ones (C4) evaluated in PaCa-44 cells maintained in Adhesion culture condition at 1 g or in SMG for 1, 7 or 9 days. All data are expressed as mean ± sd of 3 different replicates. * 0.05, ** &lt; 0.005; *** &lt; 0.0005. For all the panels T1, T7 and T9 represent 1, 7 or 9 days in simulated microgravity (SMG, respectively)</p></caption><graphic xlink:href="18_2022_4243_Fig4_HTML" id="MO4"/></fig></p>
                <p id="Par55">HIF-1α, is a key regulator of cancer-related metabolic pathways, including glycolysis, gluconeogenesis, the Tricarboxylic acid (TCA) cycle, as well as metabolism of nucleotides, amino acids and lipids. According to oxygen availability, HIF-1α dynamically regulates glucose metabolism in order to reduce reactive oxygen species (ROS) accumulation, maintain redox homeostasis and sustain cell survival. Proteomic analysis indicated an inhibition of the HIF-1α signaling at 24 h and 7 days in SMG (Fig. <xref rid="Fig4" ref-type="fig">4</xref>F); at 9 days instead, the pathway was upregulated, in line with the over time increased dimension (and necrotic core) of spheroids. HIF activation regulates the fate of pyruvate produced by glycolysis, triggering the production of Acetyl-CoA to provide cells with substrates involved in the membrane biogenesis, orchestrated by fatty acid (FA) and phospholipids synthesis, energy production by TCA cycle and post-translational modification, such as protein acetylation. To better clarify the alteration in lipid catabolism and synthesis, lipidomic analysis was performed at the three time points of SMG exposure. 447 lipids belonging to 18 different lipid classes were identified in PaCa-44 cells (Fig. <xref rid="Fig4" ref-type="fig">4</xref>G), with Triacylglycerols (TGs) as the most abundant lipid class. Monoacylglycerols were not identified whereas only few diacylglycerols were detected, most likely for their re-esterification in TGs (Jones et al., 2019). The hierarchical clustering heat-map analysis (Fig. <xref rid="Fig4" ref-type="fig">4</xref>H) highlighted specific SMG-induced lipidomic profiles for each time point. Total TG levels decreased at 1 and 7 days in SMG, while increased at 9 days (F<xref rid="Fig4" ref-type="fig">i</xref>g. <xref rid="Fig4" ref-type="fig">4</xref>I). On the contrary, both total lysophosphatidylcholines (LPCs), lysophosphatidylethanolamine (LPEs) and polyunsaturated FAs increased at 1 and 7 days in SMG to then shrank at 9 days (F<xref rid="Fig4" ref-type="fig">i</xref>g. <xref rid="Fig4" ref-type="fig">4</xref>I). Interestingly, almost all the modulated FAs (FA 20:3, FA 20:4, FA 20:5, FA22:5 and FA 22:6) were polyunsaturated (Fig. <xref rid="Fig4" ref-type="fig">4</xref>L) that may potentially be used as signaling molecules or as substrates for obtaining energy through β-oxidation. Concomitantly, the lysophospholipids increase, at 7 days, may sustain a deep membrane phospholipid remodeling as revealed by the increment of TGs together with the reduction of LPCs, LPsE and FAs (on the 9th day). These results suggest the synthesis of novel TGs and phosphatidylcholines (PCs) at prolonged exposure to SMG (9 days), probably to sustain the request of membrane lipids. In particular, we observed an increase of PC 18:1_20:4; PC 18:0_20:4, PC O-18:1_20:4 and PE 16:0_18:0 (Fig. <xref rid="Fig4" ref-type="fig">4</xref>M), supporting the hypothesis of a remodeling of the cellular membrane. Furthermore, at the same time point (9 days) the marked TG increase may be explained with their packaging into lipid droplets, which have been shown to accumulate in hypoxic conditions and to be associated with higher tumor aggressiveness [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
                <p id="Par56">Concerning polyunsaturated FAs including arachidonic acid (FA 20:4) released on the 9<sup>th</sup> day, we speculate a role for arachidonic acid and its bioactive derivatives in inflammation and in local signaling of CSCs. Indeed, the high degree of unsaturation makes these metabolites reactive and susceptible to oxygenation and hydrogenation reactions, suggesting metabolic flexibility that allows cells to adapt their metabolism to survive in hostile conditions, typical of CSCs [<xref ref-type="bibr" rid="CR21">21</xref>]. Moreover, we investigated whether free FAs may be coupled with CoA to form acyl-CoA moieties that are then transferred to carnitine to generate acylcarnitine, which subsequently enters the mitochondrial matrix via the carnitine shuttle [<xref ref-type="bibr" rid="CR22">22</xref>]. In order to understand if there is an impairment of the β-oxidation over time, we focused our attention on the acylcarnitine class. The acylcarnitine to L-carnitine ratio is recognized as a marker of carnitine deficiency and is associated with mitochondrial β-oxidation [<xref ref-type="bibr" rid="CR23">23</xref>]. In addition, the trend of this ratio is also maintained between long-intermediate-chain acylcarnitines (C16-20) compared to short-chain ones (C4). Our data showed an increased (C16-20)/(C4) ratio over time, suggesting an impairment of the β-oxidation (Fig. <xref rid="Fig4" ref-type="fig">4</xref>N) [<xref ref-type="bibr" rid="CR24">24</xref>].</p>
                <p id="Par57">At 9 days of SMG exposure, we observed upregulation of several proteins involved in metabolic-related pathways such as autophagy (LAMP1, SQSTM1), mitochondrial activity (ATP5B, ATP5A1, ATP5P0, VDAC2, ATP6V1A, COX4I1, HSD17B10, HADHA, PRDX5), TCA cycle (DLST) and Pentose phosphate pathway (PGLS, Fig. <xref rid="Fig5" ref-type="fig">5</xref>A). Other pathways are involved in the glucose fate decision, including the phosphatidylinositol‐3‐kinase/Akt (PI3k/Akt) pathway, which is also a key regulator of apoptosis and cell proliferation. In our setting, we observed upregulation of PI3K/Akt signaling already on the 1<sup>st</sup> and the 7<sup>th</sup> day of exposure to SMG (Fig. <xref rid="Fig5" ref-type="fig">5</xref>B). Interestingly, after 9 days in SMG the pathway was downregulated (Fig. <xref rid="Fig5" ref-type="fig">5</xref>B, T9 SMG). These results, together with the upregulation of proteins involved in autophagy, suggest the cell capability of activating alternative survival mechanisms. The crosstalk between apoptosis, which invariably leads to cell death, and autophagy, which has pro-survival functions is complex. To clarify this aspect, we evaluated, at the different time points of SMG exposure, key genes of the apoptotic signaling. qRT-PCR analysis indicated a higher expression after 9 days of all the pro-apoptotic genes evaluated (i.e. Caspase 9,8,3, Bax, Bad and Trail, Fig. <xref rid="Fig5" ref-type="fig">5</xref>C). Tunel staining on spheroids collected on the 9th day in SMG showed apoptotic signals on the outer membrane of the structure (Fig. <xref rid="Fig5" ref-type="fig">5</xref>D) suggesting an external layer of apoptotic cells. Accordingly, MTT assay demonstrated a lower signal on cells maintained for 9 days in spheroid-forming culture condition both at 1 g and in SMG, compared to adhesion condition (Fig. <xref rid="Fig5" ref-type="fig">5</xref>E).<fig id="Fig5"><label>Fig. 5</label><caption><p>Simulated microgravity-mediated tumor cell reprogramming. <bold>A</bold> Average logarithmic fold change of proteins involved in metabolic-related pathways evaluated in PaCa-44 cells maintained in SMG for 9 days; in green proteins downregulated while in red proteins upregulated compared to adhesion culture conditions. <bold>B</bold> Average logarithmic fold change of proteins involved in PI3K/Akt signaling evaluated in PaCa-44 cells maintained in SMG for 1, 7 or 9 days (T1, T7 and T9 SMG, respectively); in green proteins downregulated while in red proteins upregulated compared to adhesion culture conditions. <bold>C</bold> qRT-PCR analysis of pro and anti-apoptotic genes in PaCa-44 cells maintained in normal culture condition (Adhesion) or in SMG for 1, 7 or 9 days (T1, T7 and T9 SMG, respectively). Data are expressed as mean ± sem of n = 3 replicates. *0.05; ***0.0002; **** &lt; 0.0001. <bold>D</bold> One representative picture of immunofluorescence analysis for apoptosis (Tunel expression) on spheroids obtained on the 9th day in SMG. Scale bar 50 μm. <bold>E</bold> MTT assay in PaCa-44 cells maintained in normal adhesion culture condition (Adhesion), spheroid-forming condition (T9 Spheroid 1 g) or SMG (T9 SMG) for 9 days. Data are expressed as mean ± sem of <italic>n</italic> = 6 replicates</p></caption><graphic xlink:href="18_2022_4243_Fig5_HTML" id="MO5"/></fig></p>
              </sec>
            </sec>
            <sec id="Sec20">
              <title>Discussion</title>
              <p id="Par58">Understanding the impact of altered gravity on tumor cells represents the starting point for the development of novel anti-cancer therapies. We evaluated the impact of SMG to PDAC cells (PaCa-44) performing a comprehensive proteomic, lipidomic and transcriptomic analysis at different time points (1, 7 and 9 days); the major results have been confirmed in other two PDAC cell lines: CFPAC-1 and AsPC-1. Our aim was to elucidate the time-dependent modification induced by the alteration of the gravity force. Our data clearly indicated that SMG impacts in a time-dependent manner on the structural, metabolic and migratory profile of tumor cells selecting an aggressive subset endowed with stem-like features.</p>
              <p id="Par59">Dissecting cell alterations induced by SMG, we speculate that in the first 24 h, to survive SMG exposure, cells collect energy in form of ATP activating the degradation of long FAs through β-oxidation in the peroxisome. This is suggested by acylcarnitine decrease and consequent impairment of mitochondrial β-oxidation together with the upregulation of acyl-CoA dehydrogenase very long (ACADV). Altogether these observations, and the fact that FAs may enter the peroxisome via ABC carrier system rather than the carnitine shuttle, suggest that there is involvement of peroxisomes in very long FA degradation rather than the classical mitochondrial β-oxidation pathway in the early days of SMG exposure. In this way, the acetyl-CoA produced by peroxisomes is used by the mitochondrial TCA cycle to support energy consumption due to cell respiration. Indeed, at this time point, the spheroids present small dimensions and are mainly composed of aggregated cells. The upregulation at 1 day of RhoA and Cdc42 signaling contributes to dynamic actin rearrangements required for cell migration which became more evident at longer time points of SMG exposure. Indeed, Cdc42 promotes cell protrusion with formation of a leading edge where a localized actin polymerization moves forward to the membrane in filopodia and lamellipodia, generating the locomotive force. On the other hand, RhoA regulates the assembly of actomyosin filaments whose contractile force induces the retraction of the cell tail [<xref ref-type="bibr" rid="CR25">25</xref>]. The prolonged exposure (7 days) to SMG triggers actin upregulation, cytoskeleton rearrangement and deep cellular metabolic alterations to overcome the hypoxic-core formation within the spheroidal structure. Cells upregulate glycolytic enzymes (GAPDH, ENO and PKM) in order to use glucose as energy substrate in an anaerobic manner (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). The cellular machinery is involved in the synthesis of new phospholipids (as indicated by the increase in total LPCs, LPEs and in particular species of PCs and PEs) and FAs, to sustain the formation of novel membrane lipids. We observed an increase in total FAs, comprising arachidonic acid. It has been demonstrated that PI3K/mTOR/PKC axis induces calcium-dependent phospholipase A2 (cPLA2) involved in the release of arachidonic acid, oleic acid (FA 18:1) and other bioactive lipids (such as eicosanoids) [<xref ref-type="bibr" rid="CR26">26</xref>]. Remarkably, arachidonic acid and derived eicosanoids may have a role in CSC proliferation and be involved in the aggressive phenotype of CSCs [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. However, both the pathways sustaining stemness (i.e. IL-8 and NF-κB) and the CSC markers are not upregulated. Only at a longer time point, the selection of a stem-enriched and more aggressive subset of cells is significant. Indeed, after 9 days of SMG exposure we observed upregulation of IL-8 and NF-κB pathways that promoted expression of cell adhesion molecules and proteins involved in the invasion process (e.g. matrix metalloproteinases), characteristic of cancer stemness [<xref ref-type="bibr" rid="CR29">29</xref>]. Moreover, NF-κB is an upstream modulator of cyclooxygenase-2 (COX-2) acting as a procarcinogenenic enzyme. COX-2 can promote tumor growth and progression activating mechanisms including immune evasion and increased invasiveness through EMT processes [<xref ref-type="bibr" rid="CR29">29</xref>]. Indeed, on the 9th day we observed higher expression of all the evaluated mesenchymal markers and higher cell migration capability, suggesting the complete transformation towards a more stem and aggressive phenotype induced by SMG exposure, as indicated also by upregulation of EpCAM and other stemness-associated markers (Nanog, Sox2 and Oct4). NF-kB regulation is integrated in a very complex network of molecular and metabolic pathways [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Indeed, CSCs are endowed with a more active glycolysis that leads to a higher pyruvate production, which in turn fuels ATP synthesis involved in the regulation of metastasizing and aggressiveness. In line, 9 days after SMG exposure, cells undergo a profound membrane remodeling through the synthesis of PCs from LPCs and FAs. It has been shown that PCs work as oncogenic signals [<xref ref-type="bibr" rid="CR32">32</xref>] triggering cell proliferation and tumor growth. At this time point, we observed a reduction in total LPCs and LPEs as well as FsA. The LPCs produced at 7 days could be used together with neosynthesized FAs (such as palmitate) as supported by FASN upregulation and ECHS1 downregulation. In addition, to synthetize FAs, cells could use acetyl-CoA produced by glycolysis (GLUT1 and the other glycolytic enzyme are upregulated at this time point) and by glutamine metabolism (upregulation of SLC1A5). The surplus of pyruvate produced by glycolysis is extruded from the cells through LDHA transporter in the form of lactate favoring the acidification of the extracellular milieu, supporting the aggressive and migratory phenotype of the cells. Moreover, enhanced glucose uptake may also sustain the production of NADPH by the pentose phosphate pathway, a glycolytic flux shunt, as indicated by upregulation of PGLS. In turn, NADPH is the essential coenzyme for FAs neosynthesis and consequent formation of TGs, which may be used for either energy starvation (lipid droplets) or for membrane biosynthesis.<fig id="Fig6"><label>Fig. 6</label><caption><p>Schematic illustration of the effects of simulated microgravity (SMG) on PaCa-44 cells. Under SMG, the cells leave their adhesion elongated shape and aggregate in 3D spheroidal structures. Indeed, SMG impacts on cellular morphology through the modulation of proteins involved in Cdc42 and RhoA signaling that in turn affect cytoskeletal organization, neo-angiogenesis and stemness. Cytoskeletal reorganization impairs cell biological processes and induces cancer cells to activate survival mechanisms, among which the unfolded protein response (UPR) pathway, which supports autophagy to prevent cell death. The morphological rearrangement occurring during SMG additionally induces metabolic reprogramming orchestrated by the activation of HIF-1α and PI3K/Akt pathways, which pave the way for glucose metabolism upregulation. A more active glycolysis, compared to adhesion condition, is involved in the regulation of proliferation, metastasization, and aggressiveness. These metabolic changes, together with activation of PI3K/Akt/NF-κB/ERK5/IL-8 signaling axis induce the upregulation of stem-associated proteins and expansion of the CSC subset that supports neoplastic progression through EMT</p></caption><graphic xlink:href="18_2022_4243_Fig6_HTML" id="MO6"/></fig></p>
              <p id="Par60">All together, these results describe time by time cell transformation toward a more stem and aggressive phenotype induced by SMG exposure. This cell rearrangement may also affect tumour cells susceptibility to drugs, thus future works will focus on the evaluation of pancreatic cancer cells response to anti neoplastic drugs under simulated microgravity.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Information</title>
              <sec id="Sec21">
                <p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="18_2022_4243_MOESM1_ESM.docx"><caption><p>Supplementary file1 (DOCX 450 KB)</p></caption></media></supplementary-material></p>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>AA</term>
                  <def>
                    <p id="Par5">Arachidonic acid</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CSC</term>
                  <def>
                    <p id="Par6">Cancer stem cell</p>
                  </def>
                </def-item>
                <def-item>
                  <term>EMT</term>
                  <def>
                    <p id="Par7">Epithelial-to-mesenchymal transition</p>
                  </def>
                </def-item>
                <def-item>
                  <term>FA</term>
                  <def>
                    <p id="Par8">Fatty acid</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PC</term>
                  <def>
                    <p id="Par9">Phosphatidylcholine</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PDAC</term>
                  <def>
                    <p id="Par10">Pancreatic ductal adenocarcinoma</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PE</term>
                  <def>
                    <p id="Par11">Phosphatidylethanolamine</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LPC</term>
                  <def>
                    <p id="Par12">Lysophosphatidylcholine</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LPE</term>
                  <def>
                    <p id="Par13">Lysophosphatidylethanolamine</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ROS</term>
                  <def>
                    <p id="Par14">Reactive oxygen species</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RPM</term>
                  <def>
                    <p id="Par15">Random Positioning Machine</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SMG</term>
                  <def>
                    <p id="Par16">Simulated microgravity</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TCA</term>
                  <def>
                    <p id="Par17">Tricarboxylic acid</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TG</term>
                  <def>
                    <p id="Par18">Triglyceride/triacylglycerol</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
              <fn>
                <p>Maria Angela Masini, Valentina Bonetto, Marcello Manfredi and Anna Pastò contributed equally to the work.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>Not applicable</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Author contributions</title>
              <p>Conceptualization: MAM, TS, SA, DM, ME; methodology: MAM, BV, MMPA, BE, TS VVV, RE, MF, AF, DM; validation: BV, MM, PA, MF, SA FA; formal analysis: BV, MM, PA, FA, BE, VVV, RE, AF, TS, DM; investigation: MAM, BV, MM, PA, BE, VVV, MF, AF; resources: MAM, MM, TS, SA, DM; data curation: BV, MM, PA, BE, TS, VVV, RE, MF, AF, DM; writing—original draft: MAM, MM, PA, DM, ME; writing—review and editing: MAM, BV, MM, PA, BE, TS, SA, DM, ME; supervision: MAM, MM, PA, SA, DM, ME; Project administration: MAM, ME; funding acquisition: MAMSA, D.M., M.E. All authors read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>This study was supported by the AGING Project—Department of Excellence—DIMET, by “progetto FAR-2017 di Ateneo”, Università del Piemonte Orientale; Associazione Italiana per la Ricerca sul Cancro (AIRC) IG no. 19885 to A.S. and AIRC 5 × 1000 no. 22757; Ministero della Salute RF-2016-02364842 and Ministero Università Ricerca (project no. 2017BA9LM5_001); Associazione “Augusto per la Vita” Novellara (RE); and Associazione “Medicine Rocks”, Milano.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data availability</title>
              <p>The mass spectrometry proteomics data, dataset identifier PXD028708, have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/">https://www.ebi.ac.uk/pride/archive/</ext-link>). Dataset identifier proteomic analysis: PXD028708. Reviewer account details: Username: reviewer_pxd028708@ebi.ac.uk; Password<bold>:</bold> fId4pe3W.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1" notes-type="COI-statement">
                <title>Conflict of interests</title>
                <p id="Par61">The authors declare no conflict of interests.</p>
              </notes>
              <notes id="FPar2">
                <title>Ethics approval</title>
                <p id="Par62">Not applicable.</p>
              </notes>
              <notes id="FPar3">
                <title>Consent for publication</title>
                <p id="Par63">All authors give consent for the publication of the manuscript on Molecular Cancer.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Winnard</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Nasser</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Debuse</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Stokes</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Evetts</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Wilkinson</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hides</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Caplan</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>Systematic review of countermeasures to minimise physiological changes and risk of injury to the lumbopelvic area following long-term microgravity</article-title>
                  <source>Musculoskelet Sci Pract</source>
                  <year>2007</year>
                  <volume>1</volume>
                  <fpage>S5</fpage>
                  <lpage>S14</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.msksp.2016.12.009</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kimlin</surname>
                      <given-names>LC</given-names>
                    </name>
                    <name>
                      <surname>Casagrande</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Virador</surname>
                      <given-names>VM</given-names>
                    </name>
                  </person-group>
                  <article-title>In vitro three-dimensional (3D) models in cancer research: an update</article-title>
                  <source>Mol Carcinog</source>
                  <year>2013</year>
                  <volume>52</volume>
                  <issue>Suppl 3</issue>
                  <fpage>167</fpage>
                  <lpage>182</lpage>
                  <pub-id pub-id-type="doi">10.1002/mc.21844</pub-id>
                  <?supplied-pmid 22162252?>
                  <pub-id pub-id-type="pmid">22162252</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <mixed-citation publication-type="other">Vidyasekar P, Shyamsunder P, Arun R, Santhakumar R, Kapadia NK Kumar R, Verma RS (2015) Genome Wide Expression Profiling of Cancer Cell Lines Cultured in Microgravity Reveals Significant Dysregulation of Cell Cycle and MicroRNA Gene Networks<italic>. PLoS One</italic> 10(8):e0135958. 10.1371/journal.pone.0135958</mixed-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <mixed-citation publication-type="other">Kopp S, Slumstrup L, Corydon TJ, Sahana J, Aleshcheva G, Islam T, Magnusson NE, Wehland M, Bauer J, Infanger M, Grimm D (2016) Identifications of novel mechanisms in breast cancer cells involving duct-like multicellular spheroid formation after exposure to the Random Positioning Machine. Sci Rep 6:268–287. 10.1038/srep26887.</mixed-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Masini</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Strollo</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Ricci</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Pastorino</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Uva</surname>
                      <given-names>BM</given-names>
                    </name>
                  </person-group>
                  <article-title>Microtubules disruption and repair phenomena in cultured glial cells under microgravity</article-title>
                  <source>Grav Space Biol</source>
                  <year>2006</year>
                  <volume>19</volume>
                  <fpage>149</fpage>
                  <lpage>150</lpage>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ulbrich</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Schulz</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Saar</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Hübner</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Hauslage</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hemmersbach</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Braun</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Differential gene regulation under altered gravity conditions in follicular thyroid cancer cells: relationship between the extracellular matrix and the cytoskeleton</article-title>
                  <source>Cell Physiol Biochem</source>
                  <year>2011</year>
                  <volume>28</volume>
                  <fpage>185</fpage>
                  <lpage>198</lpage>
                  <pub-id pub-id-type="doi">10.1159/000331730</pub-id>
                  <?supplied-pmid 21865726?>
                  <pub-id pub-id-type="pmid">21865726</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mukhopadhyay</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Saha</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Palanisamy</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ghosh</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Biswas</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Roy</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Pal</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Sarkar</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Bagh</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>A systems biology pipeline identifies new immune and disease related molecular signatures and networks in human cells during microgravity exposure</article-title>
                  <source>Sci Rep</source>
                  <year>2016</year>
                  <volume>6</volume>
                  <fpage>259</fpage>
                  <lpage>275</lpage>
                  <pub-id pub-id-type="doi">10.1038/srep25975</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhao</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Umeshappa</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Freywald</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Xiang</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Simulated microgravity promotes cell apoptosis through suppressing Uev1A/TICAM/TRAF/NF-kappaB-regulated anti-apoptosis and p53/PCNA- and ATM/ATR-Chk1/2-controlled DNA-damage response pathways</article-title>
                  <source>J Cell Biochem</source>
                  <year>2016</year>
                  <volume>117</volume>
                  <fpage>2138</fpage>
                  <lpage>2148</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcb.25520</pub-id>
                  <?supplied-pmid 26887372?>
                  <pub-id pub-id-type="pmid">26887372</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Borst</surname>
                      <given-names>AG</given-names>
                    </name>
                    <name>
                      <surname>van Loon</surname>
                      <given-names>JJWA</given-names>
                    </name>
                  </person-group>
                  <article-title>Technology and developments for the random positioning machine</article-title>
                  <source>RPM Microgravity Sci Technol</source>
                  <year>2009</year>
                  <volume>21</volume>
                  <fpage>287</fpage>
                  <lpage>292</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12217-008-9043-2</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Aleshcheva</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>van Loon</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Growing tissues in a real and simulated microgravity: new method for tissue engineering</article-title>
                  <source>Tissue Eng Part B Rev</source>
                  <year>2014</year>
                  <volume>20</volume>
                  <fpage>555</fpage>
                  <lpage>566</lpage>
                  <pub-id pub-id-type="doi">10.1089/ten.teb.2013.0704</pub-id>
                  <?supplied-pmid 24597549?>
                  <pub-id pub-id-type="pmid">24597549</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pedrazzi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Vercellone</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Barberis</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Capraro</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>De Tullio</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Cresta</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Casciaro</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Castellani</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Patrone</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Marengo</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Identification of potential leukocyte biomarkers related to drug recovery of CFTR: clinical applications in cystic fibrosis</article-title>
                  <source>Int J Mol Sci</source>
                  <year>2021</year>
                  <volume>22</volume>
                  <fpage>3928</fpage>
                  <pub-id pub-id-type="doi">10.3390/ijms22083928</pub-id>
                  <?supplied-pmid 33920274?>
                  <pub-id pub-id-type="pmid">33920274</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dalla Pozza</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Manfredi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Brandi</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Buzzi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Conte</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Pacchiana</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Cecconi</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Marengo</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Donadelli</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: an in depth proteomic study</article-title>
                  <source>J Cell Biochem</source>
                  <year>2017</year>
                  <volume>119</volume>
                  <fpage>2696</fpage>
                  <lpage>2707</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcb.26436</pub-id>
                  <?supplied-pmid 29095525?>
                  <pub-id pub-id-type="pmid">29095525</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Manfredi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Brandi</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Di Carlo</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Vanella</surname>
                      <given-names>VC</given-names>
                    </name>
                    <name>
                      <surname>Barberis</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Marengo</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Mining cancer biology through bioinformatic analysis of proteomic data</article-title>
                  <source>Expert Rev Proteomics</source>
                  <year>2019</year>
                  <volume>16</volume>
                  <fpage>733</fpage>
                  <lpage>747</lpage>
                  <pub-id pub-id-type="doi">10.1080/14789450.2019.1654862</pub-id>
                  <?supplied-pmid 31398064?>
                  <pub-id pub-id-type="pmid">31398064</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barberis</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Joseph</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Amede</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Clavenna</surname>
                      <given-names>MG</given-names>
                    </name>
                    <name>
                      <surname>La Vecchia</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Sculco</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Aspesi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Occhipinti</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Robotti</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Boldorini</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Marengo</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Dianzani</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Manfredi</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>A new method for investigating microbiota-produced small molecules in adenomatous polyps</article-title>
                  <source>Anal Chim Acta</source>
                  <year>2021</year>
                  <volume>1179</volume>
                  <fpage>338841</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.aca.2021.338841</pub-id>
                  <?supplied-pmid 34535255?>
                  <pub-id pub-id-type="pmid">34535255</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yamazaki</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Kurisu</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Takenawa</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Regulation of cancer cell motility through actin reorganization</article-title>
                  <source>Cancer Sci</source>
                  <year>2005</year>
                  <volume>96</volume>
                  <fpage>379</fpage>
                  <lpage>386</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1349-7006.2005.00062.x</pub-id>
                  <?supplied-pmid 16053508?>
                  <pub-id pub-id-type="pmid">16053508</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Burke</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>CL</given-names>
                    </name>
                  </person-group>
                  <article-title>The nuclear lamins: flexibility in function</article-title>
                  <source>Nat Rev Mol Cell Biol</source>
                  <year>2013</year>
                  <volume>14</volume>
                  <fpage>13</fpage>
                  <lpage>24</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrm3488</pub-id>
                  <?supplied-pmid 23212477?>
                  <pub-id pub-id-type="pmid">23212477</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Singh</surname>
                      <given-names>JK</given-names>
                    </name>
                    <name>
                      <surname>Simões</surname>
                      <given-names>BM</given-names>
                    </name>
                    <name>
                      <surname>Howell</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Farnie</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Clarke</surname>
                      <given-names>RB</given-names>
                    </name>
                  </person-group>
                  <article-title>Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells</article-title>
                  <source>Breast Cancer Research: BCR</source>
                  <year>2013</year>
                  <volume>15</volume>
                  <fpage>210</fpage>
                  <pub-id pub-id-type="doi">10.1186/bcr3436</pub-id>
                  <?supplied-pmid 24041156?>
                  <pub-id pub-id-type="pmid">24041156</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pereira</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Gomes</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Borralho</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Rodrigues</surname>
                      <given-names>CMP</given-names>
                    </name>
                  </person-group>
                  <article-title>MEK5/ERK5 activation regulates colon cancer stem-like cell properties</article-title>
                  <source>Cell Death Discov</source>
                  <year>2019</year>
                  <volume>5</volume>
                  <fpage>68</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41420-019-0150-1</pub-id>
                  <?supplied-pmid 30774996?>
                  <pub-id pub-id-type="pmid">30774996</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Walcher</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Kistenmacher</surname>
                      <given-names>AK</given-names>
                    </name>
                    <name>
                      <surname>Suo</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Kitte</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Dluczek</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Strauß</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Blaudszun</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Yevsa</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Fricke</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Kossatz-Boehlert</surname>
                      <given-names>U</given-names>
                    </name>
                  </person-group>
                  <article-title>Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies</article-title>
                  <source>Front Immunol</source>
                  <year>2020</year>
                  <volume>11</volume>
                  <fpage>1280</fpage>
                  <pub-id pub-id-type="doi">10.3389/fimmu.2020.01280</pub-id>
                  <?supplied-pmid 32849491?>
                  <pub-id pub-id-type="pmid">32849491</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jones</surname>
                      <given-names>DT</given-names>
                    </name>
                    <name>
                      <surname>Valli</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Haider</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Smethurst</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Schug</surname>
                      <given-names>ZT</given-names>
                    </name>
                    <name>
                      <surname>Peck</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Aboagye</surname>
                      <given-names>EO</given-names>
                    </name>
                    <name>
                      <surname>Critchlow</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Schulze</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>3D growth of cancer cells elicits sensitivity to kinase inhibitors but not lipid metabolism modifiers</article-title>
                  <source>Mol Cancer Ther</source>
                  <year>2019</year>
                  <volume>2</volume>
                  <fpage>376</fpage>
                  <lpage>388</lpage>
                  <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-17-0857</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yanes</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Clark</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Patti</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Sánchez-Ruiz</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Benton</surname>
                      <given-names>HP</given-names>
                    </name>
                    <name>
                      <surname>Trauger</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Desponts</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Ding</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Siuzdak</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Metabolic oxidation regulates embryonic stem cell differentiation</article-title>
                  <source>Nat Chem Biol</source>
                  <year>2010</year>
                  <volume>6</volume>
                  <fpage>411</fpage>
                  <lpage>417</lpage>
                  <pub-id pub-id-type="doi">10.1038/nchembio.364</pub-id>
                  <?supplied-pmid 20436487?>
                  <pub-id pub-id-type="pmid">20436487</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Visweswaran</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Arfuso</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Warrier</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Dharmarajan</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells</article-title>
                  <source>Stem Cells</source>
                  <year>2020</year>
                  <volume>38</volume>
                  <fpage>6</fpage>
                  <lpage>14</lpage>
                  <pub-id pub-id-type="doi">10.1002/stem.3101</pub-id>
                  <?supplied-pmid 31648395?>
                  <pub-id pub-id-type="pmid">31648395</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yoshihisa</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Watanabe</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Yokokawa</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Misaka</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Sato</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Oikawa</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Kobayashi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Takeishi</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Associations between acylcarnitine to free carnitine ratio and adverse prognosis in heart failure patients with reduced or preserved ejection fraction</article-title>
                  <source>ESC Heart Fail</source>
                  <year>2017</year>
                  <volume>4</volume>
                  <fpage>360</fpage>
                  <lpage>364</lpage>
                  <pub-id pub-id-type="doi">10.1002/ehf2.12176</pub-id>
                  <?supplied-pmid 28772033?>
                  <pub-id pub-id-type="pmid">28772033</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Afshinnia</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Rajendiran</surname>
                      <given-names>TM</given-names>
                    </name>
                    <name>
                      <surname>Soni</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Byun</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Wernisch</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sas</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Hawkins</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bellovich</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Gipson</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Michailidis</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Impaired <italic>β</italic>-oxidation and altered complex lipid fatty acid partitioning with advancing CKD</article-title>
                  <source>J Am Soc Nephrol</source>
                  <year>2018</year>
                  <volume>29</volume>
                  <fpage>295</fpage>
                  <lpage>306</lpage>
                  <pub-id pub-id-type="doi">10.1681/ASN.2017030350</pub-id>
                  <?supplied-pmid 29021384?>
                  <pub-id pub-id-type="pmid">29021384</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zegers</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Friedl</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Rho GTPases in collective cell migration</article-title>
                  <source>Small GTPases</source>
                  <year>2014</year>
                  <volume>5</volume>
                  <fpage>e28997</fpage>
                  <pub-id pub-id-type="doi">10.4161/sgtp.28997</pub-id>
                  <?supplied-pmid 25054920?>
                  <pub-id pub-id-type="pmid">25054920</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Koundouros</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Karali</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Tripp</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Valle</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Inglese</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Perry</surname>
                      <given-names>NJS</given-names>
                    </name>
                    <name>
                      <surname>Magee</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Anjomani Virmouni</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Elder</surname>
                      <given-names>GA</given-names>
                    </name>
                    <name>
                      <surname>Tyson</surname>
                      <given-names>AL</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Metabolic fingerprinting links oncogenic PIK3CA with enhanced arachidonic acid-derived eicosanoids</article-title>
                  <source>Cell</source>
                  <year>2020</year>
                  <volume>181</volume>
                  <fpage>1596</fpage>
                  <lpage>1611</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cell.2020.05.053</pub-id>
                  <?supplied-pmid 32559461?>
                  <pub-id pub-id-type="pmid">32559461</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bennett</surname>
                      <given-names>DT</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>XS</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Bell</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Mauchley</surname>
                      <given-names>DC</given-names>
                    </name>
                    <name>
                      <surname>Meng</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Reece</surname>
                      <given-names>TB</given-names>
                    </name>
                    <name>
                      <surname>Fullerton</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Weyant</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Cancer stem cell phenotype is supported by secretory phospholipase A2 in human lung cancer cells</article-title>
                  <source>Ann Thorac Surg</source>
                  <year>2014</year>
                  <volume>98</volume>
                  <fpage>439</fpage>
                  <lpage>445</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.athoracsur.2014.04.044</pub-id>
                  <?supplied-pmid 24928671?>
                  <pub-id pub-id-type="pmid">24928671</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bellamkonda</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Chandrashekar</surname>
                      <given-names>NK</given-names>
                    </name>
                    <name>
                      <surname>Osman</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Selvanesan</surname>
                      <given-names>BC</given-names>
                    </name>
                    <name>
                      <surname>Savari</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sjölander</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model</article-title>
                  <source>BMC Cancer</source>
                  <year>2016</year>
                  <volume>16</volume>
                  <fpage>425</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12885-016-2466-z</pub-id>
                  <?supplied-pmid 27388564?>
                  <pub-id pub-id-type="pmid">27388564</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hashemi Goradel</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Najafi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Salehi</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Farhood</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Mortezaee</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Cyclooxygenase-2 in cancer: A review</article-title>
                  <source>J Cell Physiol</source>
                  <year>2019</year>
                  <volume>234</volume>
                  <fpage>5683</fpage>
                  <lpage>5699</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcp.27411</pub-id>
                  <?supplied-pmid 30341914?>
                  <pub-id pub-id-type="pmid">30341914</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <mixed-citation publication-type="other">Pastò A, Bellio C, Pilotto G, Ciminale V, Silic-Benussi M, Guzzo G, Rasola A, Frasson C, Nardo G, Zulato E, et al (2010) Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation and resist glucose deprivation. <italic>Oncotarget</italic> 5:4305–4319. 10.18632/oncotarget.2010.</mixed-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pagotto</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pilotto</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Mazzoldi</surname>
                      <given-names>EL</given-names>
                    </name>
                    <name>
                      <surname>Nicoletto</surname>
                      <given-names>MO</given-names>
                    </name>
                    <name>
                      <surname>Frezzini</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Pastò</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Amadori</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells</article-title>
                  <source>Cell Death Dis</source>
                  <year>2017</year>
                  <volume>87</volume>
                  <fpage>e2943</fpage>
                  <pub-id pub-id-type="doi">10.1038/cddis.2017.327</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <mixed-citation publication-type="other">Bi J, Ichu TA, Zanca C, Yang H, Zhang W, Gu Y, Chowdhry S, et al (2019) Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling. <italic>Cell Metab</italic> 3;30(suppl 3):525–538.e8. 10.1016/j.cmet.2019.06.014.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
